CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
Rigshospitalet, Denmark
300 participants
Apr 1, 2024
INTERVENTIONAL
Conditions
Summary
The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD). Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD. Participants will be subject to several examinations, including blood tests, urine samples, ECG, echocardiography, and bone scintigraphy. An endomyocardial biopsy may be conducted if necessary.
Eligibility
Inclusion Criteria1
- No signs of CAD through Rb-PET and/or CT coronary arteriogram
Exclusion Criteria1
- Previous history of amyloidosis
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Clinical examination, blood samples, echo, bone scintigraphy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07435168